Search results summary

From Health Canada

New search

Search criteria

  • Status: Select all
  • Company: UCB CANADA INC

Search results

List of returned drug products
Products returned by the search are listed, including their status, DIN number, name, class, total count of active ingredients and the name of one, etc. Clicking on the value in the DIN column returns more complete information about the related product.
Status DIN Company Product Class PM See footnote1 Schedule # See footnote2 A.I. name See footnote3 Strength
Marketed 02525267 UCB CANADA INC BIMZELX Human Yes Schedule D 1 BIMEKIZUMAB 160 MG / ML
Marketed 02525267 UCB CANADA INC BIMZELX Human Yes Prescription 1 BIMEKIZUMAB 160 MG / ML
Marketed 02525275 UCB CANADA INC BIMZELX Human Yes Prescription 1 BIMEKIZUMAB 160 MG / ML
Marketed 02525275 UCB CANADA INC BIMZELX Human Yes Schedule D 1 BIMEKIZUMAB 160 MG / ML
Approved 02553619 UCB CANADA INC BIMZELX Human Yes Prescription 1 BIMEKIZUMAB 320 MG / 2 ML
Approved 02553619 UCB CANADA INC BIMZELX Human Yes Schedule D 1 BIMEKIZUMAB 320 MG / 2 ML
Approved 02553627 UCB CANADA INC BIMZELX Human Yes Prescription 1 BIMEKIZUMAB 320 MG / 2 ML
Approved 02553627 UCB CANADA INC BIMZELX Human Yes Schedule D 1 BIMEKIZUMAB 320 MG / 2 ML
Marketed 02452936 UCB CANADA INC BRIVLERA Human Yes Prescription 1 BRIVARACETAM 10 MG
Marketed 02452944 UCB CANADA INC BRIVLERA Human Yes Prescription 1 BRIVARACETAM 25 MG
Marketed 02452952 UCB CANADA INC BRIVLERA Human Yes Prescription 1 BRIVARACETAM 50 MG
Marketed 02452960 UCB CANADA INC BRIVLERA Human Yes Prescription 1 BRIVARACETAM 75 MG
Marketed 02452979 UCB CANADA INC BRIVLERA Human Yes Prescription 1 BRIVARACETAM 100 MG
Marketed 02452987 UCB CANADA INC BRIVLERA Human Yes Prescription 1 BRIVARACETAM 10 MG / ML
Marketed 02452995 UCB CANADA INC BRIVLERA Human Yes Prescription 1 BRIVARACETAM 10 MG / ML
Marketed 02331675 UCB CANADA INC CIMZIA Human Yes Schedule D 1 CERTOLIZUMAB PEGOL 200 MG / ML
Marketed 02331675 UCB CANADA INC CIMZIA Human Yes Prescription 1 CERTOLIZUMAB PEGOL 200 MG / ML
Marketed 02465574 UCB CANADA INC CIMZIA Human Yes Prescription 1 CERTOLIZUMAB PEGOL 200 MG / ML
Marketed 02465574 UCB CANADA INC CIMZIA Human Yes Schedule D 1 CERTOLIZUMAB PEGOL 200 MG / ML
Marketed 02247027 UCB CANADA INC KEPPRA Human Yes Prescription 1 LEVETIRACETAM 250 MG
Marketed 02247028 UCB CANADA INC KEPPRA Human Yes Prescription 1 LEVETIRACETAM 500 MG
Marketed 02247029 UCB CANADA INC KEPPRA Human Yes Prescription 1 LEVETIRACETAM 750 MG
Marketed 02403897 UCB CANADA INC NEUPRO Human Yes Prescription 1 ROTIGOTINE 1 MG / 24 HOUR
Marketed 02403900 UCB CANADA INC NEUPRO Human Yes Prescription 1 ROTIGOTINE 2 MG / 24 HOUR
Marketed 02403919 UCB CANADA INC NEUPRO Human Yes Prescription 1 ROTIGOTINE 3 MG / 24 HOUR
Marketed 02403927 UCB CANADA INC NEUPRO Human Yes Prescription 1 ROTIGOTINE 4 MG / 24 HOUR
Marketed 02403935 UCB CANADA INC NEUPRO Human Yes Prescription 1 ROTIGOTINE 6 MG / 24 HOUR
Marketed 02403943 UCB CANADA INC NEUPRO Human Yes Prescription 1 ROTIGOTINE 8 MG / 24 HOUR
Marketed 02357615 UCB CANADA INC VIMPAT Human Yes Prescription 1 LACOSAMIDE 50 MG
Marketed 02357623 UCB CANADA INC VIMPAT Human Yes Prescription 1 LACOSAMIDE 100 MG
Marketed 02357631 UCB CANADA INC VIMPAT Human Yes Prescription 1 LACOSAMIDE 150 MG
Marketed 02357658 UCB CANADA INC VIMPAT Human Yes Prescription 1 LACOSAMIDE 200 MG
Marketed 02357666 UCB CANADA INC VIMPAT Human Yes Prescription 1 LACOSAMIDE 10 MG / ML
Approved 02549220 UCB CANADA INC ZILBRYSQ Human Yes Prescription 1 ZILUCOPLAN (ZILUCOPLAN SODIUM) 16.6 MG / 0.416 ML
Approved 02549239 UCB CANADA INC ZILBRYSQ Human Yes Prescription 1 ZILUCOPLAN (ZILUCOPLAN SODIUM) 23 MG / 0.574 ML
Approved 02549247 UCB CANADA INC ZILBRYSQ Human Yes Prescription 1 ZILUCOPLAN (ZILUCOPLAN SODIUM) 32.4 MG / 0.81 ML
New search

Application information

Related information

Contact us

Version 4.0.3
Report a problem or mistake on this page

"Page details"

Date modified: